News & Events

RAMOT@TAU awarded U.S. patent for novel coronavirus vaccine design

19 April 2020
The patent covers a vaccine that targets the most vulnerable point in a coronavirus’s structure, through which it penetrates human cells. The patent has been submitted by Ramot, the technology transfer company of Tel-Aviv University and was granted in March by the U.S. patent and trademark office.

Innocan Pharma collaborates with RAMOT@TAU to develop a new revolutionary approach to treat the Covid -19 Corona Virus with exosomes-loaded CBD

17 April 2020
Herzeliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 17, 2020) - InnoCan Pharma Corporation (CSE: INNO) ("InnoCan" or the "Company") announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement dated April 17, 2020 (the "Research Agreement") with Ramot at Tel Aviv University ("Ramot") to collaborate with Tel Aviv university to develop a novel, revolutionary approach to treat COVID-19 by using Cannabidiol (CBD) loaded Exosomes ("ICLX").

Cancer treatment co Kahr Medical raises $18m

26 February 2020
Cancer treatment co Kahr Medical raises $18m - Jerusalem-based cancer treatment startup Kahr Medical Ltd. has raised $18 million. The round was led by Flerie Invest AB, Oriella Limited, Hadasit Bio-Holdings (HBL), Pavilion Capital, and Mirae Asset Venture.

Researchers at Ben-Gurion University Introduce Platform for the Design of New Antibiotics

10 February 2020
BEER-SHEVA, Israel – February 10, 2020 - BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a novel method developed by researchers at Ben-Gurion University for screening and detecting new antibiotics.

Ananda Scientific and Ben-Gurion University to Develop Cannabis Products

20 November 2019
GREENWOOD, Colorado — November 19, 2019 — ANANDA Scientific today announced it has entered into a license and research agreement with BGN Technologies (BGN), the technology transfer company of Ben-Gurion University of the Negev, Israel, to develop and commercialize cannabinoid products for topical applications.


4-7 November 2019
AUTM ASIA 2019 is your chance to learn from the best international tech transfer professionals around the globe! You will gain valuable insights from international government, academic and industry sectors which will highlight the basic principles of tech transfer as well as explore the monumental changes occurring the tech transfer eco system today.
AUTM ASIA 2019 will showcase powerful stories at the intersection of invention, innovation and commercialization to provide valuable expertise and know-how to navigate the next era of tech transfer.

Wohl Institute for Translational Medicine Inaugurated at Hadassah Medical Organization in Jerusalem

29 October 2019
Applied Research for Personalized Medicine The Wohl Institute offers state-of-the-art imaging technologies for preclinical research The research at the Wohl Institute will promote the development of dedicated medications and treatments.

Allied Corp., a Medical Cannabis Company, signs Master Services Agreement with Carmel

28 October 2019
Allied Corp. ("Allied") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, has entered into a Master Services Agreement with the University of Haifa, Israel via their wholly owned commercialization subsidiary: Carmel - Haifa University Economic Corporation Ltd. (“Haifa”).

AI Peptide Startup Pepticom Raises $5 Million

24 October 2019
Jerusalem-based Pepticom Ltd. has raised $5 million in a series A funding round, the company announced Thursday. Founded in 2011, Pepticom uses artificial intelligence algorithms to design peptide drug candidates based on the known structure of the required target proteins.

ITTN Annual PDF Report 2018

12 August 2019
The Israel Tech Transfer Network, ITTN, is pleased to present its first annual report. In 2018, the 166 technology transfer professionals acting for ITTN’s 15 members produced a remarkable deal flow and over 1,000 new patent disclosures.
ITTN’s mission is to maintain and enhance our members’ contribution by developing our professional capacities, generating novel best practices, formulating new collaborations, and building dialogue with our partners in industry and government.